Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
Jul 30, 2020 Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian Therapeutic Goods Administration
Jul 27, 2020 COVID-19 IgG/IgM Rapid Test Cassette Distributed by Aytu BioScience Featured in Business Insider Article
Jul 20, 2020 Aytu BioScience Announces Expansion of NATESTO(R) U.S. Commercial Team
Jul 10, 2020 Aytu BioScience Announces Distribution Partnership with Apollo Med Innovations to Expand Distribution of COVID-19 IgG/IgM Rapid Test in United States
Jun 09, 2020 Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid Test

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 1.28
Volume 1.56 million
Day Range 1.28 - 1.31
52 Week Range 0.34 - 2.99
Bid/Ask 1.29 / 1.30
Bid/Ask Size 55,700 X 1,500
Previous Close 1.31
Market Cap 155.59 million
Shares Outstanding 120.62 million
Dividend/Yield 0.00 / 0.00%
EPS (TTM) -1.313600
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
May 15, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Feb 14, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Nov 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 26, 2019 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
May 14, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director